Jawaharlal Nehru Cancer Hospital & Research Centre is a private-sector cancer care hospital in Bhopal, India. It was founded in 1995 by Madhya Pradesh Cancer Chikitsa Evam Seva Samiti.

During the past decade, Jawaharlal Nehru Cancer Hospital and Research Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jawaharlal Nehru Cancer Hospital and Research Centre" #1 sponsor was "Eisai Inc." with 1 trials, followed by "Gemin X" with 1 trials sponsored, "Helsinn Therapeutics (U.S.), Inc" with 1 trials sponsored, "Light Sciences Oncology" with 1 trials sponsored and "Poniard Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jawaharlal Nehru Cancer Hospital and Research Centre" #1 collaborator was "Cephalon" with 1 trials as a collaborator and "PharmaBio Development Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Jawaharlal Nehru Cancer Hospital and Research Centre" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Colorectal Cancer" (1 trials), "Colorectal Neoplasms" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials) and "Liver Metastases" (1 trials). Many other conditions were trialed in "Jawaharlal Nehru Cancer Hospital and Research Centre" in a lesser frequency.

Most popular intervention types in "Jawaharlal Nehru Cancer Hospital and Research Centre" are "Drug" (5 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin/etoposide" (1 trials), "FOLFIRI plus Bevacizumab" (1 trials), "FOLFIRI regimen" (1 trials), "FOLFOX4 regimen" (1 trials) and "FOLIRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jawaharlal Nehru Cancer Hospital and Research Centre" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Jawaharlal Nehru Cancer Hospital and Research Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Jawaharlal Nehru Cancer Hospital and Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jawaharlal Nehru Cancer Hospital and Research Centre, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".